HuGE Literature Finder
Records
1
-
7
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
Gene polymorphisms in dual antiplatelet therapy and the presence of hypo-attenuated leaflet thickening after transcatheter aortic valve replacement. Journal of thrombosis and thrombolysis 2018 Feb . Xiong Tian-Yuan, Liao Yan-Biao, Feng Yuan, Zhao Ming-Yue, Zhao Zhen-Gang, Li Yi-Jian, Liu Xiao-Jing, Chen M |
Integrative Medicine on Optimizing Clopidogrel and Aspirin Therapy. Chinese journal of integrative medicine 2018 Jan . Chen H |
Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation. Gene 2016 Jun . Zhang Hongshen, Ma Kezhong, Liu Wenwei, Yang Feng, Liu Jianfei, Zhou Hany |
Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm. Pharmacogenetics and genomics 2014 Oct 24 (10): 501-13. Jiménez-Varo Enrique, Cañadas-Garre Marisa, Gutiérrez-Pimentel María J, Calleja-Hernández Miguel |
Pharmacogenetics role in the safety of acenocoumarol therapy. Thrombosis and haemostasis 2014 Sep 112 (3): 522-36. Jiménez-Varo E, Cañadas-Garre M, Henriques C I, Pinheiro A M, Gutiérrez-Pimentel M J, Calleja-Hernández M |
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. The New England journal of medicine 2010 Oct 363 (18): 1704-14. Paré Guillaume, Mehta Shamir R, Yusuf Salim, Anand Sonia S, Connolly Stuart J, Hirsh Jack, Simonsen Katy, Bhatt Deepak L, Fox Keith A A, Eikelboom John |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 09, 2022
- Content source: